Affordable Access

deepdyve-link
Publisher Website

Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6)

Authors
  • Dangi, Bindi
  • Obeng, Marcus
  • Nauroth, Julie M.
  • Chung, Gloria
  • Bailey-Hall, Eileen
  • Hallenbeck, Todd
  • Arterburn, Linda M.
Type
Published Article
Journal
Biochemical Pharmacology
Publisher
Elsevier
Publication Date
Jan 01, 2009
Accepted Date
Aug 04, 2009
Volume
79
Issue
2
Pages
251–260
Identifiers
DOI: 10.1016/j.bcp.2009.08.001
Source
Elsevier
Keywords
License
Unknown

Abstract

17S-HDPAn-6 (17S-hydroxydocosa-4 Z,7 Z,10 Z,13 Z,15 E-pentaenoic acid) and 10S,17S-HDPAn-6 (10S,17S-dihydroxydocosa-4 Z,7 Z,11 E,13 Z,15 E-pentaenoic acid) are potent anti-inflammatory resolvins derived from DPAn-6 (docosapentaenoic acid n-6) and are analogous in structure and action to DHA (docosahexaenoic acid)-derived resolvins. These resolvins have proven to be potential drug candidates, albeit with therapeutic profiles that need optimization. The main objectives of this study were to evaluate key features of DPAn-6 derived resolvins that are important for therapeutic efficacy, demonstrate that these DPAn-6 resolvins could be produced naturally, and could therefore have physiological significance. Here we demonstrate biological production, examine pharmacokinetic profiles and identify key routes of metabolic inactivation of DPAn-6 derived resolvins. We compare their metabolic stability to a known resolvin, 17S-HDHA (17S-hydroxydocosa-4 Z,7 Z,10 Z,13 Z,15 E,19Z-hexaenoic acid) and show that order of their stabilities is 10S,17S-HDPAn-6 > 17S-HDPAn-6 > 17S-HDHA. We show that both these compounds are not strong inhibitors of cytochrome-P450 enzymes. We evaluate activity of compounds in the delayed-type hypersensitivity model, results of which show that compounds need optimization for enhanced duration and magnitude of action. Analysis of the metabolic stability and identification of metabolites of these compounds could play an important role in the design of better analogs with longer durations of action and hence better efficacy.

Report this publication

Statistics

Seen <100 times